FDA Approved Medical Products for:

Japanese encephalitis

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Japanese encephalitis vaccine, inactivated, adsorbed
Trade Name
(Manufacturer Name)
Ixiaro
(Intercell AG)
Indication
The FDA has approved this product to be used in this manner.
Treatment of infants, children, and adolescents 2 months to less than 17 years of age for active immunization for the prevention of disease caused by Japanese encephalitis virus.
More Information about this product Drug Information Portal
Medline Plus Health Information